Lv2
130 积分 2021-09-16 加入
Pancreatic ductal adenocarcinoma and its subtypes: clinical relevance of histopathology and molecular characterization, integrating the key updates of the 2026 WHO classification
10天前
已完结
How Should the Lower Limit of the Normal Range Be Defined?
16天前
已完结
Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases
23天前
已完结
Phase I Study of Bevacizumab Added to Fluorouracil- and Hydroxyurea-Based Concomitant Chemoradiotherapy for Poor-Prognosis Head and Neck Cancer
23天前
已完结
Amino acid PET imaging to monitor mIDH inhibitor treatments in patients with refractory IDH-mutant gliomas
1个月前
已完结
Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study
1个月前
已完结
Belzutifan versus Everolimus for Advanced Renal-Cell Carcinoma
1个月前
已完结
Transarterial chemoembolisation combined with lenvatinib plus pembrolizumab versus dual placebo for unresectable, non-metastatic hepatocellular carcinoma (LEAP-012): a multicentre, randomised, double-blind, phase 3 study
1个月前
已完结
Pembrolizumab plus trastuzumab and chemotherapy for HER2-positive gastric or gastro-oesophageal junction adenocarcinoma: interim analyses from the phase 3 KEYNOTE-811 randomised placebo-controlled trial
1个月前
已完结
Pembrolizumab plus Axitinib versus Sunitinib for Advanced Renal-Cell Carcinoma
1个月前
已完结
皖公网安备34019202002308
